Table 3.

Comparison of the Removal of Iron and Porphyrin Accumulation in the Liver Induced by Hydroxypyridinone Chelators

TreatmentNonheme Iron (μg/g liver)FerritinFerritin Iron (μg/g liver)Ferrochelatase Activity (nmol/h/mg)Protoporphyrin (nmol/g liver)
(% of control)
Control 55 ± 5 100 ± 27 6.8 ± 1.4 12.9 ± 3.9 0.4 ± 0.1 
CP20 33 ± 13-150 72 ± 153-150 1.8 ± 0.33-150 8.2 ± 3.9 3.2 ± 3.9 
CP94 36 ± 23-150 68 ± 103-150 2.1 ± 0.23-150 8.1 ± 1.73-150 17.1 ± 15.93-150 
CP102 44 ± 73-150 78 ± 223-150 2.9 ± 0.63-150 14.9 ± 5.1 0.3 ± 0.1 
CP117 36 ± 23-150 60 ± 73-150 3.1 ± 0.83-150 ND 0.6 ± 0.1 
TreatmentNonheme Iron (μg/g liver)FerritinFerritin Iron (μg/g liver)Ferrochelatase Activity (nmol/h/mg)Protoporphyrin (nmol/g liver)
(% of control)
Control 55 ± 5 100 ± 27 6.8 ± 1.4 12.9 ± 3.9 0.4 ± 0.1 
CP20 33 ± 13-150 72 ± 153-150 1.8 ± 0.33-150 8.2 ± 3.9 3.2 ± 3.9 
CP94 36 ± 23-150 68 ± 103-150 2.1 ± 0.23-150 8.1 ± 1.73-150 17.1 ± 15.93-150 
CP102 44 ± 73-150 78 ± 223-150 2.9 ± 0.63-150 14.9 ± 5.1 0.3 ± 0.1 
CP117 36 ± 23-150 60 ± 73-150 3.1 ± 0.83-150 ND 0.6 ± 0.1 

C57BL/10 ScSn mice received CP20, CP94, and CP102 in the drinking water at 2 mg/mL and CP117 at 3 mg/mL for 2 weeks. Values are the means of 5 mice per group.

Abbreviation: ND, not determined.

F3-150

Significantly different from control, P < .05.

or Create an Account

Close Modal
Close Modal